|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
|
|
2
|
Kucukmetin A, Biliatis I, Ratnavelu N,
Patel A, Cameron I, Ralte A and Naik R: Laparoscopic radical
trachelectomy is an alternative to laparotomy with improved
perioperative outcomes in patients with early-stage cervical
cancer. Int J Gynecol Cancer. 24:135–140. 2014. View Article : Google Scholar
|
|
3
|
Rijkmans EC, Nout RA, Rutten IH, Ketelaars
M, Neelis KJ, Laman MS, Coen VL, Gaarenstroom KN, Kroep JR and
Creutzberg CL: Improved survival of patients with cervical cancer
treated with image-guided brachytherapy compared with conventional
brachytherapy. Gynecol Oncol. 135:231–238. 2014. View Article : Google Scholar
|
|
4
|
Tewari KS, Sill MW, Long HJ III, Penson
RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao
MM, et al: Improved survival with bevacizumab in advanced cervical
cancer. N Engl J Med. 370:734–743. 2014. View Article : Google Scholar
|
|
5
|
Weinmann S, Williams AE, Kamineni A, Buist
DS, Masterson EE, Stout NK, Stark A, Ross TR, Owens CL, Field TS
and Doubeni CA: Cervical cancer screening and follow-up in 4
geographically diverse US health care systems, 1998 through 2007.
Cancer-Am Cancer Soc. 121:2976–2983. 2015.
|
|
6
|
Koskas M, Rodier JM, Bretel JJ, Bonneau C,
Luton D, Touboul C and Rouzier R: Life after uterine cancer. Rev
Prat. 64:816–820. 2014.
|
|
7
|
Gien LT and Covens A: Lymph node
assessment in cervical cancer: Prognostic and therapeutic
implications. J Surg Oncol. 99:242–247. 2009. View Article : Google Scholar
|
|
8
|
Caley DP, Pink RC, Trujillano D and Carter
DR: Long noncoding RNAs, chromatin and development.
ScientificWorldJournal. 10:90–102. 2010. View Article : Google Scholar
|
|
9
|
Lee JT, Davidow LS and Warshawsky D: Tsix,
a gene antisense to Xist at the X-inactivation centre. Nat Genet.
21:400–404. 1999. View
Article : Google Scholar
|
|
10
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010. View Article : Google Scholar
|
|
11
|
Ravasi T, Suzuki H, Pang KC, Katayama S,
Furuno M, Okunishi R, Fukuda S, Ru K, Frith MC, Gongora MM, et al:
Experimental validation of the regulated expression of large
numbers of non-coding RNAs from the mouse genome. Genome Res.
16:11–19. 2006. View Article : Google Scholar
|
|
12
|
Gibb EA, Becker-Santos DD, Enfield KS,
Guillaud M, Niekerk Dv, Matisic JP, Macaulay CE and Lam WL:
Aberrant expression of long noncoding RNAs in cervical
intraepithelial neoplasia. Int J Gynecol Cancer. 22:1557–1563.
2012. View Article : Google Scholar
|
|
13
|
Cao S, Liu W, Li F, Zhao W and Qin C:
Decreased expression of lncRNA GAS5 predicts a poor prognosis in
cervical cancer. Int J Clin Exp Pathol. 7:6776–6783. 2014.
|
|
14
|
Jiang S, Wang HL and Yang J: Low
expression of long non-coding RNA LET inhibits carcinogenesis of
cervical cancer. Int J Clin Exp Pathol. 8:806–811. 2015.
|
|
15
|
Jiang Y, Li Y, Fang S, Jiang B, Qin C, Xie
P, Zhou G and Li G: The role of MALAT1 correlates with HPV in
cervical cancer. Oncol Lett. 7:2135–2141. 2014. View Article : Google Scholar
|
|
16
|
Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang
SB, Jin ZJ, Sun SH, Wang F and Li W: Long noncoding RNA-EBIC
promotes tumor cell invasion by binding to EZH2 and repressing
E-cadherin in cervical cancer. PLoS One. 9:e1003402014. View Article : Google Scholar
|
|
17
|
Jing L, Yuan W, Ruofan D, Jinjin Y and
Haifeng Q: HOTAIR enhanced aggressive biological behaviors and
induced radio-resistance via inhibiting p21 in cervical cancer.
Tumour Biol. 36:3611–3619. 2015. View Article : Google Scholar
|
|
18
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Sui W, Lin H, Peng W, Huang Y, Chen J,
Zhang Y and Dai Y: Molecular dysfunctions in acute rejection after
renal transplantation revealed by integrated analysis of
transcription factor, microRNA and long noncoding RNA. Genomics.
102:310–322. 2013. View Article : Google Scholar
|
|
21
|
Kanehisa M, Goto S, Sato Y, Furumichi M
and Tanabe M: Tanabe, KEGG for integration and interpretation of
large-scale molecular data sets. Nucleic Acids Res. 40:D109–D114.
2012. View Article : Google Scholar
|
|
22
|
Gene Ontology Consortium, . Gene ontology,
gene ontology consortium: Going forward. Nucleic Acids Res.
43:D1049–D1056. 2015. View Article : Google Scholar
|
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar
|
|
24
|
Luo R, Zhang M, Liu L, Lu S, Zhang CZ and
Yun J: Decrease of fibulin-3 in hepatocellular carcinoma indicates
poor prognosis. PLoS One. 8:e705112013. View Article : Google Scholar
|
|
25
|
Su PH, Lin YW, Huang RL, Liao YP, Lee HY,
Wang HC, Chao TK, Chen CK, Chan MW, Chu TY, et al: Epigenetic
silencing of PTPRR activates MAPK signaling, promotes metastasis
and serves as a biomarker of invasive cervical cancer. Oncogene.
32:15–26. 2013. View Article : Google Scholar
|
|
26
|
Chen Q, Cao HZ and Zheng PS: LGR5 promotes
the proliferation and tumor formation of cervical cancer cells
through the Wnt/β-catenin signaling pathway. Oncotarget.
5:9092–9105. 2014.
|
|
27
|
QI P and Du X: The long non-coding RNAs, a
new cancer diagnostic and therapeutic gold mine. Mod Pathol.
26:155–165. 2013. View Article : Google Scholar
|
|
28
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar
|
|
29
|
Valle-Mendiola A, Weiss-Steider B,
Rocha-Zavaleta L and Soto-Cruz I: IL-2 enhances cervical cancer
cells proliferation and JAK3/STAT5 phosphorylation at low doses,
while at high doses IL-2 has opposite effects. Cancer Invest.
32:115–125. 2014. View Article : Google Scholar
|
|
30
|
Xiang T, Du L, Pham P, Zhu B and Jiang S:
Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell
cycle arrest in human cervical cancer cells via the ROS-dependent
mitochondrial pathway. Cancer Lett. 364:79–88. 2015. View Article : Google Scholar
|
|
31
|
Pahne-Zeppenfeld J, Schröer N,
Walch-Rückheim B, Oldak M, Gorter A, Hegde S and Smola S: Cervical
cancer cell-derived interleukin-6 impairs CCR7-dependent migration
of MMP-9-expressing dendritic cells. Int J Cancer. 134:2061–2073.
2014. View Article : Google Scholar
|
